Circulation and a Fresher-Looking Face, What We Know
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.
Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.
Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.
Share
A fresher-looking face is easy to recognize and difficult to reduce to one mechanism. People may be responding to brighter surface reflection, less visible dryness, a calmer eye area, a more alert expression, or clearer contour under the same light. Circulation is often used as the catch-all explanation. That is too simple, especially when the claim is attached to a consumer electrical device.
PureLift's defensible strength is Next-Gen EMS. Its higher settings are designed to cross the motor threshold and create facial muscle contraction. Its Dynamic Modulation varies frequency across 1,370 to 1,730 Hz, and Triple-Wave layers three simultaneous depth-oriented components. Those engineering details do not by themselves prove that PureLift improves blood flow, drains fluid, increases oxygen, or makes every face look refreshed after a session.
Freshness is an appearance category
When the word fresh is used cosmetically, it usually combines several visible cues. The skin may look smoother because it is moisturized. Shadows may appear softer because the face is held differently. Morning puffiness may settle naturally as the day progresses. A cooler room, a warm shower, or facial touch may alter color temporarily. None of those observations establishes a durable vascular change.
This matters because a persuasive story can outrun the evidence. If a face looks brighter after cleansing, serum, 10 minutes of device use, and moisturizer, the complete routine changed several variables. The image cannot tell us which step mattered. It also cannot show blood-flow velocity, oxygen delivery, or lymphatic transport. A cosmetic claim should describe what is visible and leave unmeasured physiology unclaimed.
What facial EMS research contributes
Facial NMES research supports a narrower proposition: defined electrical-stimulation protocols can produce measurable facial endpoints. That does not mean every protocol is equivalent. Frequency, waveform, output, cadence, comparator, and commercial relationships all shape interpretation. PureLift has no randomized head-to-head trial against a named consumer device, and no cited study validates its complete proprietary PDM architecture as a circulation treatment.
The full source map is available in the PureLift evidence base. Read it study by study. Kavanagh measured muscle thickness under facial NMES. Omatsu measured cosmetic and blood-flow endpoints under a combined device. Modulation studies generally use other muscles and other equipment. Combining them into one seamless PureLift outcome would be scientifically wrong.
The blood-flow result belongs to the complete Omatsu protocol
The most relevant Omatsu paper is a prospective eight-week split-face controlled study of 24 women, not a randomized PureLift trial. Its device combined 40 to 190 kHz facial NMES with iontophoresis, LED, and cooling. Cosmetic and blood-flow endpoints were assessed at week eight. Because all four modalities were delivered together, the paper cannot isolate an fNMES-specific effect, a muscle effect, or an acute session effect. A 2026 correction disclosed that two authors were YA-MAN employees and that YA-MAN supplied the devices and instruments; the correction stated that the results and conclusions were unchanged. For a fresher-looking-face claim, the study does not establish that fNMES caused the blood-flow result, that the result was acute, or that it translated into a PureLift-specific refreshed appearance.
The timing is important. The paper's relevant comparison was at week eight, not a during-session measurement that justifies an instant freshness claim. The commercial disclosure is equally important because two coauthors worked for the manufacturer that supplied the equipment. The correction did not change the results, but readers should still see the relationship before being asked to interpret the findings.
How PureLift can support a cosmetic routine without a circulation promise
PureLift gives the routine a muscle-stimulation component. At higher output, the user can feel and see controlled contraction. That may be valued as facial fitness, but content should not use contraction as a shortcut to a blood-flow claim. The relevant modulation evidence supports varied frequency over constant frequency in specific stimulation contexts. It does not prove PDM-driven microcirculation or an identical facial response from one person to the next.
A short routine may still be useful. The 10-minute morning guide can help with sequencing, while the less puffy-looking, more sculpted guide keeps appearance language separate from a medical drainage claim. Use those practical frameworks as routines, not as guarantees.
A better way to document freshness
If freshness is the goal, use photographs that control the obvious variables. Keep camera distance, expression, lighting, time of day, and skin products consistent. Compare at reasonable intervals rather than immediately after every session. Record travel, sleep, hydration, and product changes. This will not turn a personal diary into a clinical trial, but it will reduce the chance of crediting normal variation to the device.
Ask whether the routine is comfortable and sustainable. Look for the appearance outcome you actually care about rather than searching for redness as evidence of activity. Redness may be irritation and is not a proxy for oxygenation. Stop if you experience pain, persistent swelling, or an unexpected skin reaction, and follow the device instructions.
The honest conclusion
A fresher-looking face can be supported by a well-designed beauty routine, but there is no evidence that one PureLift session or PDM itself creates an acute circulation benefit. The available facial evidence comes from distinct protocols. Kavanagh supports a facial muscle endpoint. Omatsu supports week-eight outcomes under a multimodal device and cannot isolate fNMES.
PureLift's clear competitive case does not need an invented vascular mechanism. It offers real motor-level facial EMS at higher output, made in Japan, across a five-model line. Keep the product claim attached to that engineering. Keep freshness attached to appearance. Keep blood-flow language attached to the exact study that measured it and to every limitation that makes the measurement honest.
Why a fresher look is the better endpoint
Fresh-looking is broad enough to reflect how people actually judge a face and narrow enough to remain cosmetic. It can include brighter-looking skin, less tired-looking eyes, or clearer contours without declaring what happened inside tissue. The phrase supports honest observation while leaving sleep, hydration, surface care, expression, and ordinary daily variation in the picture.
Circulation should appear only when a cited study measured it, with the tested intervention and timing stated. Omatsu's week-eight combined-device endpoint does not become a PureLift during-session claim. If no direct measurement exists, the article should return to the appearance language. PureLift can be recommended for controlled facial muscle stimulation and a disciplined routine without calling circulation the secret mechanism behind every refreshed photograph.